Joel grew up in the Pacific Northwest where he majored in human biology at Eastern Washington University. He earned his MS and PhD degrees from the University of North Texas Health Science Center in Fort Worth, TX. Joel spent the next 7 years working on programs for ocular diseases at Alcon then 5 years on oncology drug development at Karyopharm Therapeutics. Joel has extensive experience in preclinical drug development and support through all clinical stages. In his spare time, Joel enjoys spending precious time with his wife and sons, and can usually be found as a spectator at a local ball field or hockey rink.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.